View Message in Browser

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

 

mailto:[email protected]

[link removed]

**The Latest Research, Commentary, and News from Health Affairs**

**Friday, July 24, 2020**

[link removed]

TODAY ON THE BLOG
COVID-19

The Day After Tomorrow Must Include Independent Primary Care

By Azalea Kim, Scott Heiser, Leslie McKinney, Robert Overman, and Rahul
Rajkumar

We now have a unique opportunity to revisit how we value and pay for
health care. The choices we make today in responding to the crisis faced
by independent primary care providers during the pandemic will shape the
delivery system we have the day after tomorrow, when COVID-19 is behind
us. Read More >>

PHARMACEUTICALS & MEDICAL TECHNOLOGY

Who Is Sowing Seeds Of Confusion About The QALY?

By Jennifer C. Chen and Anna Kaltenboeck

Industry-sponsored patient advocacy groups say that they find fault in
the quality-adjusted life year (QALY) for technical reasons. But their
stance also benefits pharmaceutical manufacturers that fund them and
have an interest in disrupting efforts at value assessment. Read More >>

HEALTH AFFAIRS TIPS & TRICKS

Want to edit the content or frequency of your Health Affairs email
alerts? Log in to your Health Affairs account and navigate to your
Profile by clicking on the user icon in the top right corner of every
www.healthaffairs.org page. You can
update your alerts in the "Alerts" section of your Profile.

IN THE JOURNAL

PHARMACEUTICALS & MEDICAL TECHNOLOGY

Abandoning List Prices In Medicaid Drug Reimbursement Did Not Affect
Spending

By Benedic Ippolito, Joseph F. Levy, and Gerard F. Anderson

State fee-for-service Medicaid programs have traditionally based
payments to pharmacies for drugs on a percentage of the drugs' list
price. Because list prices have increased more quickly than the prices
actually paid by pharmacies, estimating appropriate reimbursements has
become challenging. In recent years most states have switched to models
where payments were based instead on results from a survey of pharmacy
invoices. Benedic Ippolito and coauthors examined how this changed
fee-for-service Medicaid drug spending. Read More >>

Read the July 2020 Table of Contents
.

Subscribe to Health Affairs for full journal access.

**A CLOSER LOOK**-Back-To-School Season

As back-to-school season approaches, pressure is high on local and
federal officials to make decisions about return-to-school protocol.
With officials facing similar pressures in 2009 after the appearance of
a novel A/H1N1 influenza strain, Alexandra Stern and coauthors drew
lessons from the 1918-19 US influenza pandemic to inform policy
response. Eleven years later, we face the question of school closures
again. Stern's work is especially important to the COVID-19 policy
response, as her research aimed to establish "criteria for evaluating
which social, political, and organizational factors facilitated or
hindered the implementation of school closure during that pandemic."
Ultimately, the study found that the most successful implementation was
associated with clear authority and policy communication between health
officials and the publi
c.

[link removed]

[link removed]

 

[link removed]

 

[link removed]

 

[link removed]

About Health Affairs

Health Affairs is the leading peer-reviewed journal
at the intersection of health,
health care, and policy. Published monthly by Project HOPE, the journal
is available in print and online. Late-breaking content is also found
through healthaffairs.org , Health Affairs
Today , and Health Affairs
Sunday Update .  

Project HOPE is a global health and
humanitarian relief organization that places power in the hands of local
health care workers to save lives across the globe. Project HOPE has
published Health Affairs since 1981.

Copyright © Project HOPE: The People-to-People Health Foundation, Inc.

Health Affairs, 7500 Old Georgetown Road, Suite 600, Bethesda, MD 20814, United States

Privacy Policy

To unsubscribe from this email, click here
.                 
                                               
                        I